reason report
bottom line remain posit op op
acut facil decent quarter solid beat
modestli posit mp though reduc
convict still see sector stock pick game
broader long hospit trade price growth biggest driver
perform quarter view combin network
contract servic line improv mix optim possibl bad
debt account offer posit surpris volum rebound
swb remain control despit wage inflat cost
effici bh continu strong us growth
rebound uk though headwind persist op still believ
get revenu growth bh though acut volum look
weak lpnt mp better expect price growth
mp latter also engag bond exchang avert near
term matur ebitda in-lin averag though notabl
beat miss
facil perform strongli ytd facil
index compar mco
 see select valu facil coverag view
see significantli multipl dispers base asset base
network ambulatori asset key driver valuat
rel in-lin quarter acut coverag see
acceler trend despit strong price driven
price solid averag elev acuiti though
opinion optim commerci mix inpati
set chang bad debt account could also driver
believ price strength could driven acut
mix patient remain hospit payor pressur member
ambulatori site care believ hospit
best posit sustain price due broad ambulatori footprint
larg invest acut servic line also chang bad debt
account could partial driver dialysi provid
mp note medicar bad debt recoveri repres
volum rel line quarter post lower
expect industri survey flu impact quarter
rel modest could see increas season high
increas pressur commerci payor shift member
ambulatori altern site care see structur
rebound medic cost trend econom cycl exhibit
mix rel stabl report largest commerci
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
edta descript benchmark avail contact leerink partner publish depart
staf wage pressur remain off-set cost
control especi mm cost save program
compani expand altern access point
thc/uspi best posit see multipl expans
due increas weight higher multipl ambulatori asset
sotp basi see valuat rang
exhibit
mp remain highli lever progress
made reduc leverag asset sale strong
guidanc mm aid nol could provid
addit opportun leverag reduct exhibit
tax reform repres ep tailwind less
lever name lpnt level play field
profit competit enabl invest servic line
remain mp beat uk busi
rebound nice though pressur like remain
nh shift referr local govern us busi
report good quarter despit nois quarter surround
sever close facil impact swb believ remain
track return normal behavior revenu growth rate
comp eas exhibit
op pt reiter contrarian view
strong structur buy hold name see weak buy
opportun qualiti pick see ebitda growth
volume price growth guidanc achiev margin
expans outsiz market share gain servic line improv
addit offer addit upsid
op pt increas convict post
beat guidanc rais special situat pick activ
support de-lever use proce conif hospit
sale opex effici execut improv ebitda growth
op pt lower ebitda estim pt
miss driven weak acut volum behavior swb bh
outpati visit pressur continu ralli return
bh revenu growth regulatori settlement
mp pt report beat nice rebound
uk still uk censu headwind driven nh process chang
toward local govern referr persist us volum solid
mp pt provid path near-term default relief
propos debt chang note still debt ratio
immin matur on-going debt re-structur keep us
lpnt mp pt lpnt report good quarter ebitda
exceed buysid expect tax polici tailwind price
margin expans delay invest altern access
point limit capital-expenditure
mp pt maintain pt ebitda estim
report in-lin quarter still litig risk headlin risk
ballot initi ca remain
remain posit acut facil decent quarter solid
beat modestli posit rais pt lptn though
reduc convict
still see sector stock pick game broader long hospit trade price growth
biggest driver perform quarter view combin
network contract servic line improv mix optim possibl bad debt
account offer posit surpris volum rebound swb remain
control despit wage inflat cost effici bh continu strong us
growth rebound uk though headwind persist still believ get
revenu growth bh though acut volum look weak lpnt better expect
price growth latter also engag bond exchang avert near term
facil perform strongli ytd facil index compar
mco see select valu facil coverag
view see significantli multipl dispers base asset base
network ambulatori asset key driver valuat rel in-lin quarter
acut coverag see acceler trend despit strong
price driven acuiti
ebitda in-lin averag though notabl beat
price solid averag elev acuiti though opinion
optim commerci mix inpati set chang bad debt account
could also driver believ price strength could driven acut mix
patient remain hospit payor pressur member ambulatori site care
believ hospit best posit sustain price due broad
ambulatori footprint larg invest acut servic line also chang bad debt
account could partial driver dialysi provid note medicar bad
debt recoveri repres revenu per treatment
guidanc estimateconsensu ebitda mm beat/ miss bp healthcar facil
also chang bad debt account could partial driver dialysi
provid note medicar bad debt recoveri repres revenu per
treatment specif highlight driver acut coverag note
facil report net revenu total uncompens care ex lpnt total
uncompens care improv yoy qoq though might compar previou
volum rel line quarter post lower expect industri
survey flu impact quarter rel modest could see increas season
hdhp penetr remain near all-tim high increas pressur
commerci payor shift member ambulatori altern site care see
structur rebound medic cost trend econom cycl
ss admiss adj admiss improv yoy lower expect
compani report qhc nr ss admin adj admin core hospit
ss ed volum improv increas lpnt report decreas ss surgeri
compani report qhc nr ss admin adj admin ed core hospit
physician servic provid report improv volum md report increas
neonat trend
hdhp penetr moder volum commerci high
though yoy growth sinc slow see structur rebound medic
cost trend econom cycl value-bas care drive continu mix shift lower cost
altern site servic
hdhp penetr remain all-tim high around neg correl
ed volum commerci cost trend kaiser data suggest hdhp
penetr rel flat strong growth sinc
see acceler trend due neg correl hdhp
volum cost trend hdhp remain time-high despit slow growth ss
ed volum growth neg correl increas hdhp penetr ss hospit
ed volum larg pressur post-aca era
non-farm payrol grow year hospit inpati admiss
declin sinc
overal spend expect grow averag rate
expenditur categori expect grow go forward hospit care
expect larg track overal spend growth payer type overal spend growth driven
growth medicar spend medicaid spend growth extent oop
pocket expens privat health insur spend expect grow rel slower
rate due repeal individu mandat beyond slower pace
growth privat health insur spend attribut part shift babi boomer
privat insur medicar growth oop expens support increas
penetr hdhp high deduct health plan
pocket paymentout pocket yoy growth expenditurehospit expens yoy growth healthcar facil
survey result indic acceler push ambulatori indic
acceler util across care deliveri set inpati outpati
ambulatori surgeri center ed despit sever flu season first half
chang average respond expect chang yoy util room healthcar facil
respond expect chang variou proceduresorthoped hips/ knee spinecardiologyentgynecologyurologyoth procedur perform ip vs op vs ltm ntminpatientoutpatientfreestand healthcar facil
mix rel stabl report largest commerci adj admiss
meaning acceler cost trend expect increas util
trend guidanc across manag care coverag support stabl margin
third parti data indic
signific acceler cost trend
staf wage pressur remain off-set cost control especi
bl compani report leerink partner llc research
leerink coverag salari benefit expens net revenu
leerink coverag oper expens net revenu
leerink coverag suppli expens net revenu
compani expand altern access point thc/uspi best
posit see multipl expans due increas weight higher
multipl ambulatori asset sotp basi see valuat rang
disclos ambulatori financi estim sotp part valuat
could yield valuat ebitda exposur higher multipl
ambulatori segment given public privat comp
ambulatori segment ebitda expand estim
sotp part valuat analysi assum conif divestitur addit
hospit divestitur current plan proce leverag
acut compani focus strategi off-set secular pressur volum
acquir divest asset meet debt commit
facilitylocationbedscommenthouston northwest medic centerhouston houston areacypress fairbank medic center hospit houston houston areapark plaza hospitalhouston houston areatombal region medic centertombal houston areasouth texa region centerjourdanton san antonio areaweatherford region medic centerweatherford dalla ft worth areahighland region medic centersebr mile west ft piercesatilla region medic centerwaycross jacksonvil area facilitiesmemori hospit savannah level picu servic level trauma servic areamiss mission acquisit march medic mission acquisit march ridg region hospitalspruc mission acquisit march mission acquisit march mission acquisit march region hospitalbrevardnapend mission acquisit march healar facil
remain highli lever progress made reduc leverag
asset sale strong guidanc mm aid nol
could provid addit opportun leverag reduct
tax reform repres ep tailwind less lever name
lpnt level play field profit competit enabl invest
tax reform repres ep tailwind less lever name lpnt
seven compani report growth capital-expenditure expect increas
averag tax reform drive increas capit spend
ebitda less chang corpor tax rate chang corpor interest incom longer subject us impact ni impact healtr facil
guidanc mm yoy growthmainten expans bed add jv de novo debt replac hospit spend target capital-expenditure focus higher return core hospit alloc higher percentag capital-expenditure toward addit access point well servic line build-out cardiolog orthoped high-acu reform drove increas cap expans plan increas ad capac improv facil enhanc expect elev new marquett mi tower project moder mm year ambulatori capit equip renov new project exist hospit expand er capac technolog construct new rev mainten healthcar facil
medacorp survey report major respond expect
chang capital-expenditure ntm spend properti plant infrastructur rank highest
among differ categori capit expenditur respond see
budgetari surplu due tax reform given non-profit natur survey could
support thesi tax reform level play field non-profit seen hca
mm increas capit expenditur
major respond expect chang capital-expenditure ntm
respond expect chang capital-expenditure respond expect budget surplu due tax reform healthcar facil
unchangedlessundecidedproperti plant clinic hcit system oper lift oncolog build new cath vinci robot mako hip/kne robot orthoped respond expect categorywis capital-expenditure chang healthcar facil
report beat uk busi rebound nice though pressur
like remain nh shift referr local govern us busi
report good quarter despit nois quarter surround sever close
facil impact swb believ remain track return normal
behavior revenu growth rate comp eas
net rev/pati day qoq yoy despit uk challeng
ss revenu trend continu improv would net
continu impact hurrican puerto rico
compani report us consolid bh adjust fx
report qoq yoy volum trend declin also
highlight sever weather northeast impact outpati visit state
hand facil impact volum compani expect ramp throughout
year
compani report us
note posit side occup rate remain high bh industri
driven overal bed shortag suppli demand dynam remain favor
player add de novo bed capac
believ bh clinic staf shortag continu swb expens key
area focu
ac jv remain opportun appear
mix issu acut refer expect add two jv
chattanooga tn ohio achc pipelin jv remain rich variou
jv approv process note mani jv acut partner close
psych unit would treat acut patient differ
note mani jv partner still oper psych unit mix referr often
weight medicaid better pay medicar commerci patient
acut coverag trade averag consensu ebitda
trade averag consensu ebitda
op pt -- reiter contrarian view strong structur buy
hold name see weak buy opportun qualiti pick
see ebitda growth volume price growth guidanc achiev
margin expans outsiz market share gain servic line improv /or addit
hca ebtida line consensu revenu ep beat
link earn report
consensusleerinkconsensusleerinkconsensusleerinkconsensusleerinkconsensusleerinkrevenu expense/net opex/net rev/ per adj admiss adj admin healthcar facil
op pt -- increas convict post beat guidanc
rais special situat pick activ support de-lever use proce
conif hospit sale opex effici execut improv ebitda growth
thc ebitda beat consensu revenu ep also beat
new ebitda estim mm mm respect driven rais
link earn report
consensusleerinkconsensusleerinkconsensusleerinkconsensusleerinkconsensusleerinkrevenu expense/net opex/net ni rev/adj admiss inpati admiss inpati equiv admin healthcar facil
op pt -- lower ebitda estim pt miss driven
weak acut volum behavior swb bh outpati visit pressur
continu ralli return bh revenu growth regulatori settlement
ebitda miss consensu revenu ep also miss
link earn report
mp pt -- report beat nice rebound uk still uk
censu headwind driven nh process chang toward local govern referr persist
us volum solid
achc ebitda beat consensu revenu ep also beat
link earn report
oper net us inpati uk inpati healthcar facil
mp pt -- provid path near-term default relief propos debt
chang note still debt ratio immin matur on-going debt re-
structur keep us sidelin
cyh revenu ebitda ep beat consensu
maintain ebitda mm mm respect
link earn report
consensusleerinkconsensusleerinkconsensusleerinkconsensusleerinkconsensusleerinkrevenu expense/net opex/net rev/per adj inpati inpati equiv healthcar facil
lpnt mp pt -- lpnt report good quarter ebitda exceed buysid
expect tax polici tailwind price margin expans delay
invest altern access point limit capital-expenditure
lpnt ebitda line consensu miss revenu ep beat
link lpnt earn report
consensusleerinkconsensusleerinkconsensusleerinkconsensusleerinkconsensusleerinkrevenu expense/net opex/net rev/adj inpati inp equiv healthcar facil
mp pt -- maintain pt ebitda estim report in-
line quarter still litig risk headlin risk ballot initi ca remain
report in-lin quarter ebitda consensu revenu though
consensu small set
link earn report
primari valuat methodolog base ev/ebitda rel rel
ev/ebitda also track function compani histori hospit group
averag assess potenti ev/ebitda expans next month base
forward forecast contempl underli fundament implic healthcar
reform dcf valuat leverag forward forecast wacc termin
growth rate point potenti multipl expans along sector company-
specif catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
market perform price target base ev/ebitda
adjust ebitda
downsid risk valuat includ
risk higher acquisit multipl slow acquisit driven growth
financi posit result oper
uk reli publicli fund entiti unit kingdom
revenu loss reduct fund chang procur method
pt contempl ev/ebitda ebitda less nci estim
downsid risk valuat includ
substanti reduct govern reimburs
lower margin shift patient privat insur provid medicar
govern program advers consequ new on-going litig
advanc non-dialysi renal replac technolog
xenotransplant develop therapi slow prevent progress
price target base pro forma ebitda leverag post transact
debt repay
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
delay time sale hospit asset initi improv physician
product expens reduct
exposur larg earn swing result high leverag
variou on-going legal proceed may result cash outflow
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
base rate outperform price target base
ev/ebitda ebitda view
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
downsid risk leverag
legisl regul cut govern commerci payer reimburs
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
point potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
lpnt market perform price target base ev/ebitda
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
downsid risk leverag
legisl regul cut government commerci payer reimburs
margin expans headwind class
lack
rate outperform price target base combin enterpris
valu ebitda multipl valuat base forward forecast contempl underli
fundament implic sum-of-the-part valuat rang
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
downsid risk leverag
legisl regul cut government commerci payer reimburs
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
point potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
outperform price target base ev/ebitda
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
acut care segment highli concentr la vega texa
cut govern commerci payer reimburs
declin receiv collect rate
pay mix pressur behavior segment
incom statement mm except provis doubt net expensessalari oper total oper ebitda compani depreci incom ebit net interest pbt incom tax net incom yoy incom attribut non-controlling net incom attribut net incom attribut averag share million dilut yoy dilut yoy growth expense/net opex/net debt/gross healthcar facil
incom statement mm except provis doubt net expensessalari oper total oper depreci incom ebit net interest pbt incom tax incom yoy incom attribut non-controlling net incom attribut net incom attribut share dilut yoy dilut yoy growth growth expense/net opex/net debt/gross healtr facil
incom statement mm except per provis doubt net expensessalari oper total oper adj ebitda depreci incom ebit net interest pbt incom tax incom continu oper yoy incom attribut non-controlling net incom attribut lpnt net incom attribut lpnt averag share million dilut yoy dilut yoy growth expense/net opex/net debt/gross healthcar facil
incom statement mm except provis doubt net expensessalari oper total oper ebitda depreci invest ebit net interest pbt incom tax incom yoy incom attribut non-controlling net incom attribut net incom attribut y-o-i chang share million dilut yoy dilut yoy growth expense/net opex/net debt/gross healar facil
incom provis doubt net expensessalari oper total oper adjust ebitda less ebitda depreci ebit net interest pbt incom tax incom yoy incom attribut non-controlling net incom attribut net incom attribut averag share million dilut yoy dilut yoy non-recur item metricsrevenu growth less nci expense/net opex/net debt/gross healthcar facil
caresam hospitalsinpati chang patient chang chang length chang caresam hospitalsinpati chang patient chang chang length chang healthcar facil
incom provis doubt net expensessalari oper ebitda depreci oper non-oper ebit net interest incom tax incom yoy net incom averag share million dilut dilut yoy non-recur item metricsrevenu growth expense/net opex/net debt/gross healthcar facil
admiss ss trend
hospit usinpati chang chang chang hospit ukinpati chang chang revenu chang healthcar facil
american renal associ hold inc incom statement mm except patient servic oper administr ebitda growth ebitda nci margin net incom incom tax less tax net incom attribut growth margin net outstand earn per growth growth healthcar facil
